Prader Willi Syndrome News and Research

RSS
Rhythm Metabolic completes $40 million Series A financing

Rhythm Metabolic completes $40 million Series A financing

Rhythm announces initiation of two setmelanotide Phase 2 trials for treatment of PWS, POMC-null obesity

Rhythm announces initiation of two setmelanotide Phase 2 trials for treatment of PWS, POMC-null obesity

Alizé Pharma presents clinical results from the AZP-531 program at the ADA 75th Scientific Sessions

Alizé Pharma presents clinical results from the AZP-531 program at the ADA 75th Scientific Sessions

Johns Hopkins researchers link sperm with specific 'epigenetic tags' to autism

Johns Hopkins researchers link sperm with specific 'epigenetic tags' to autism

Rhythm, Actavis announce initiation of relamorelin Phase 2b trial for treatment of diabetic gastroparesis

Rhythm, Actavis announce initiation of relamorelin Phase 2b trial for treatment of diabetic gastroparesis

Alizé Pharma announces launch of AZP-531 Phase II trial in patients with Prader-Willi syndrome

Alizé Pharma announces launch of AZP-531 Phase II trial in patients with Prader-Willi syndrome

Study suggests link between neonatal ghrelin and obesity risk

Study suggests link between neonatal ghrelin and obesity risk

Growth hormone boosts muscle development in Prader-Willi syndrome

Growth hormone boosts muscle development in Prader-Willi syndrome

Alizé Pharma completes two Phase I clinical trials of AZP-531 in healthy volunteers, obese subjects

Alizé Pharma completes two Phase I clinical trials of AZP-531 in healthy volunteers, obese subjects

Dosing commences in Essentialis’ DCCR clinical study in obese Prader-Willi syndrome patients

Dosing commences in Essentialis’ DCCR clinical study in obese Prader-Willi syndrome patients

‘Surprising’ effect of growth hormone on BMI in normal-weight children

‘Surprising’ effect of growth hormone on BMI in normal-weight children

Scientists report major breakthrough in understanding molecular basis for Prader-Willi syndrome

Scientists report major breakthrough in understanding molecular basis for Prader-Willi syndrome

Alize Pharma initiates AZP-531 Phase I clinical trial for treatment of type 2 diabetes

Alize Pharma initiates AZP-531 Phase I clinical trial for treatment of type 2 diabetes

Prader-Willi syndrome results in dysregulation of circadian and metabolic genes

Prader-Willi syndrome results in dysregulation of circadian and metabolic genes

University of Alberta researchers help children with Down syndrome

University of Alberta researchers help children with Down syndrome

Prader-Willi children may receive relief from sleep disorders after adenotonsillectomy

Prader-Willi children may receive relief from sleep disorders after adenotonsillectomy

People with Prader-Willi Syndrome may have impaired autonomic nervous system

People with Prader-Willi Syndrome may have impaired autonomic nervous system

Brains of people with anorexia and obesity are wired differently

Brains of people with anorexia and obesity are wired differently

Oxytocin hormone holds promise for children with Prader-Willi syndrome

Oxytocin hormone holds promise for children with Prader-Willi syndrome

PerkinElmer announces new Signature Precision Panel | Prenatal diagnostic test for chromosomal disorders

PerkinElmer announces new Signature Precision Panel | Prenatal diagnostic test for chromosomal disorders